76327-32-7

Usage

Uses

Used in Pharmaceutical Industry:
3-chloro-4-propoxybenzoic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structural features, including the chlorine and propoxy groups, allow for the development of drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3-chloro-4-propoxybenzoic acid serves as an essential building block for the creation of pesticides and other crop protection agents. Its pesticidal properties make it a valuable component in the formulation of effective and targeted agrochemical products.
Used in Organic Synthesis:
3-chloro-4-propoxybenzoic acid is utilized as a versatile starting material in organic synthesis. Its reactivity and functional groups enable the production of a wide range of compounds for various applications, further highlighting its importance in the field of chemistry.

Downstream Products

• 1034690-41-9 ethyl 3-(3-chloro-5-{5-[3-chloro-4-(propyloxy)phenyl]-1,2,4-oxadiazol-3-yl}-1H-indol-1-yl)propanoate 
• 1220973-40-9 5-(3-chloro-4-propoxyphenyl)-3-(3-iodo-4-isopropoxyphenyl)-1,2,4-oxadiazole 
• 1072947-93-3 ethyl 3-(5-{5-[3-chloro-4-(propyloxy)phenyl]-1,2,4-oxadiazol-3-yl}-1H-indazol-1-yl)propanoate 

Relevant academic research and scientific papers

S1P RECEPTORS MODULATORS

The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.

INDOLE DERIVATIVES AS S1P1 RECEPTOR AGONISTS

The invention relates to compounds of formula (I) wherein one of R5 and R6 is hydrogen or R2 and the other is (a) processes for their preparation, pharmaceutical compositions containing them and their use in the treatment

OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE (S1P) AGONISTS

The present invention provides compounds of formula (I) or salts thereof, having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors.